Last reviewed · How we verify
mannitol and sucrose
At a glance
| Generic name | mannitol and sucrose |
|---|---|
| Sponsor | Takeda |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Hypertension
- Pneumonia
- Fall
- Procedural pain
- Cardiac murmur
- Dyspnoea
- Urinary tract infection
- Oedama peripheral
- Transient ischaemic attack
- Pain in extremity
- Haemoglobin decreased
- Nausea
Key clinical trials
- Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma (PHASE2)
- POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC (PHASE1)
- Carbohydrates and Running Performance (NA)
- Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C (PHASE3)
- Genetic Carbohydrate Maldigestion As Model to Study Food Hypersensitivity Mechanism (WORK PACKAGE 2)
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects (PHASE3)
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) (PHASE3)
- Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- mannitol and sucrose CI brief — competitive landscape report
- mannitol and sucrose updates RSS · CI watch RSS
- Takeda portfolio CI